Massimo Lopez

3.0k total citations · 1 hit paper
59 papers, 2.2k citations indexed

About

Massimo Lopez is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Massimo Lopez has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 17 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Massimo Lopez's work include Cancer Treatment and Pharmacology (26 papers), Breast Cancer Treatment Studies (13 papers) and Colorectal Cancer Treatments and Studies (10 papers). Massimo Lopez is often cited by papers focused on Cancer Treatment and Pharmacology (26 papers), Breast Cancer Treatment Studies (13 papers) and Colorectal Cancer Treatments and Studies (10 papers). Massimo Lopez collaborates with scholars based in Italy, United States and Malaysia. Massimo Lopez's co-authors include Vittorio Gebbia, Giuseppe Colucci, Francesco Giuliani, Evaristo Maiello, Luigi Di Lauro, Generoso Uomo, Antonio Testa, S. Cigolari, Maria Biglietto and Paola Papaldo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Massimo Lopez

59 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2005 586 citations Giuseppe Colucci, Vittorio Gebbia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Lopez Italy	21	1.6k	598	516	405	282	59	2.2k
B. Massidda Italy	23	1.6k 1.0×	848 1.4×	662 1.3×	302 0.7×	292 1.0×	84	2.3k
Per‐Ebbe Jönsson Sweden	20	927 0.6×	434 0.7×	270 0.5×	239 0.6×	348 1.2×	35	1.5k
D. Depisch Austria	28	2.0k 1.3×	895 1.5×	386 0.7×	395 1.0×	939 3.3×	82	2.7k
S. Kakolyris Greece	32	1.9k 1.2×	925 1.5×	816 1.6×	1.0k 2.5×	254 0.9×	90	3.0k
Frank A. Scappaticci United States	22	1.4k 0.9×	856 1.4×	470 0.9×	1.2k 3.0×	271 1.0×	38	2.8k
G. Deplanque France	23	1.3k 0.8×	812 1.4×	542 1.1×	633 1.6×	225 0.8×	77	2.3k
Nobuyuki Mizunuma Japan	23	1.5k 0.9×	530 0.9×	367 0.7×	506 1.2×	259 0.9×	133	2.0k
J. L. Misset France	27	2.1k 1.3×	1.0k 1.7×	566 1.1×	433 1.1×	452 1.6×	63	3.0k
Roger Faroux France	23	1.7k 1.1×	684 1.1×	550 1.1×	311 0.8×	599 2.1×	98	2.5k
Giorgio Cocconi Italy	25	1.4k 0.9×	769 1.3×	421 0.8×	431 1.1×	311 1.1×	85	2.2k

Countries citing papers authored by Massimo Lopez

Since Specialization

Citations

This map shows the geographic impact of Massimo Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Lopez more than expected).

Fields of papers citing papers by Massimo Lopez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Lopez. The network helps show where Massimo Lopez may publish in the future.

Co-authorship network of co-authors of Massimo Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Lopez. A scholar is included among the top collaborators of Massimo Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Lopez. Massimo Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vici, Patrizia, Giuseppe Colucci, Francesco Giotta, et al.. (2011). A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. Journal of Experimental & Clinical Cancer Research. 30(1). 39–39. 18 indexed citations

Colucci, Giuseppe, Francesco Giuliani, Carlo Garufi, et al.. (2010). Cetuximab plus FOLFOX-4 in Untreated Patients with Advanced Colorectal Cancer: A Gruppo Oncologico dell’Italia Meridionale Multicenter Phase II Study. Oncology. 79(5-6). 415–422. 17 indexed citations

Trent, Jonathan C., et al.. (2010). An unusual site of metastasis from gastrointestinal stromal tumor. Rare Tumors. 2(4). 58–58. 7 indexed citations

Vici, Patrizia, et al.. (2009). Epigenome: a new target in cancer therapy.. PubMed. 159(5). 347–60. 12 indexed citations

Lopez, Massimo, et al.. (2009). [Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer].. PubMed. 160(6). 489–97. 2 indexed citations

Rossi, A., Giuseppe Russo, Raffaele La Montagna, et al.. (2009). The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. International Journal of Cancer. 125(1). 235–243. 38 indexed citations

Vici, Patrizia, Luigi Di Lauro, Domenico Sergi, et al.. (2008). A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines. Oncology. 75(3-4). 175–181. 11 indexed citations

Colucci, Giuseppe, Francesco Giuliani, Vittorio Gebbia, et al.. (1999). Epirubicin, Folinic Acid, Fluorouracil, and Etoposide in the Treatment of Advanced Gastric Cancer. American Journal of Clinical Oncology. 22(3). 262–266. 5 indexed citations

Milella, Michele Stanislaw, Cecilia Nisticò, Virginia Ferraresi, et al.. (1999). Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women. Breast Cancer Research and Treatment. 55(3). 259–266. 16 indexed citations

10.

Arcangeli, Giorgio, L. D’Angelo, Giuseppe Giovinazzo, et al.. (1998). Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiotherapy and Oncology. 46(1). 39–45. 8 indexed citations

11.

Ameglio, Franco, Anna Maria Cianciulli, Fabrizio Mattei, et al.. (1994). Selection of Patients with Monoclonal Grammopathy of Undetermined Significance is Mandatory for a Reliable Use of lnterleukin-6 and Other Nonspecific Multiple Myeloma Serum Markers. Acta Haematologica. 92(1). 1–7. 4 indexed citations

12.

Maini, C.L., A. Tofani, Rosa Sciuto, et al.. (1994). Thallium-201 Scintigraphy and Chemotherapeutic Response in Rhabdomyosarcoma. Clinical Nuclear Medicine. 19(7). 607–610. 9 indexed citations

13.

Lopez, Massimo, M. Natali, Luigi Di Lauro, et al.. (1993). Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer. 72(2). 502–505. 25 indexed citations

14.

Lopez, Massimo, et al.. (1991). Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: Preliminary results. Journal of Surgical Oncology. 48(S2). 108–111. 7 indexed citations

15.

Lopez, Massimo, Silvia Carpano, Luigi Di Lauro, Patrizia Vici, & Ettore Conti. (1991). Epirubicin and DTIC (EDIC) for Advanced Soft-Tissue Sarcomas. Oncology. 48(3). 230–233. 10 indexed citations

16.

Lopez, Massimo. (1985). Cyproterone acetate in the treatment of metastatic cancer of the male breast. Cancer. 55(10). 2334–2336. 20 indexed citations

17.

Lopez, Massimo, et al.. (1985). Hormonal Treatment of Disseminated Male Breast Cancer. Oncology. 42(6). 345–349. 40 indexed citations

18.

Lopez, Massimo, Carlo Federico Perno, Luigi Di Lauro, & Paola Papaldo. (1984). 5-Fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 12(3). 194–197. 7 indexed citations

19.

Lopez, Massimo, Luigi Di Lauro, Paola Papaldo, & Carlo Federico Perno. (1984). Alternating combination chemotherapy of advanced soft tissue sarcomas in adults. American Journal of Clinical Oncology. 7(5). 539–542. 1 indexed citations

20.

Lopez, Massimo, et al.. (1983). 5-Fluorouracil, Adriamycin and Cyclophosphamide Combined with High-Dose Medroxyprogesterone Acetate in Advanced Breast Cancer. Tumori Journal. 69(6). 545–551. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact